3Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J]. J Clin Endocrinol Metab, 2008,93 (8): 809-814.
4Bfiore E,Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease[J]. J Clin Endocrinol Metab, 2012,97(12), 1134-1145.
5Kim HK,Yoon JH,Kim SJ,et al. Higher TSH level is a risk factor for differentiated thyroid cancer[J]. Clin Endo- crinol,2012,27(3) :312-315.
6Jonklaas J, Nsouli-Maktabi H ,Soldin SJ. Endogenous thy- rotropin and triiodothyronine concentrations in individuals with thyroid cancer[J]. Mary Ann Liebert, 2008,18 (9): 943-952.
7Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role[J-. Endocr Relat Cancer, 2009,16(12) : 1251-1260.
8Rebuff at SA,Morin M,Nguyen B, et al. Human recombi nant anti thyroperoxidase autoantibodies : in vitro cytotox-ic activity on papillary thyroid cancer expressing TPO [J]. Br J Cancer,2010,102(8):852-861.
9Repplinger D,Bargren A,Zhang YW,et al. Is Hashimoto' s thyroiditis a risk factor for papillary thyroid caneer[J]. Surg Res,2008,150(1) :49-52.
